BioNxt Solutions Inc. Completes Convertible Debentures Extension and Warrant Issuance

BioNxt Solutions Inc. has finalized the extension of its unsecured convertible debentures. The revised maturity dates range from November 12, 2027, to March 14, 2028. This move covers debentures amounting to $425,000, $285,000, $1,400,000, $865,000, $1,600,000, and $900,000, maintaining an interest rate of 8% annually.

As part of the agreement, BioNxt issued 16,900,000 common share purchase warrants to debenture holders. Each warrant allows the purchase of a common share at $0.50, valid until August 21, 2027. The warrants and any subsequent shares are under a statutory hold period of four months plus a day from issuance.